Actuate Therapeutics Ownership | Who Owns Actuate Therapeutics?

Actuate Therapeutics Ownership Summary

Actuate Therapeutics is owned by 53.35% institutional investors, 18.94% insiders, and 27.71% retail investors.

ACTU Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Actuate Therapeutics	53.35%	18.94%	27.71%
Sector	Healthcare Stocks	79.82%	9.81%	10.37%
Industry	Biotech Stocks	63.50%	9.87%	26.63%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	25	31.58%	10,401,592	2.82%	53	0.37%	19	35.71%	1	-50.00%
Dec 31, 2024	19	90.00%	10,116,136	2547.05%	120	960.02%	14	40.00%	2	-
Sep 30, 2024	10	-	382,167	-	3	-	10	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 27, 2009	BEITZEL GEORGE B	-	Sell	$115.12K
Aug 26, 2009	BEITZEL GEORGE B	-	Sell	$228.84K
May 20, 2009	PATTERSON ARTHUR C	-	Sell	$50.22K
Aug 30, 2007	BEITZEL GEORGE B	-	Sell	$354.50K
Aug 31, 2007	BEITZEL GEORGE B	-	Sell	$355.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2014 Q2	-	-
2013 Q2	-	-
2012 Q4	-	-
2012 Q2	-	-

ACTU Ownership FAQ

Who Owns Actuate Therapeutics?

Actuate Therapeutics shareholders are primarily institutional investors at 53.35%, followed by 18.94% insiders and 27.71% retail investors. The average institutional ownership in Actuate Therapeutics's industry, Biotech Stocks , is 63.50%, which Actuate Therapeutics falls below.

Does Blackrock own Actuate Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Actuate Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools